Teva Pharmaceutical Industries (TEVA) FY2022 results: revenue $14.9 billion, down 6.0% on the year
Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of $14.9 billion for fiscal 2022, the year ended 31 December 2022, down 6.0% on the year before. Net income was -$2.4 billion, and diluted earnings per share $-2.20. The figures are the company's own, from the 10-K it filed with the SEC on 10 February 2023.
Revenue
$14.9 billion
-6.0% on the year
FY2015FY2022
Operating margin
-14.7%
10.8% a year earlier
FY2015FY2022
Net income
-$2.4 billion
FY2015FY2022
Diluted EPS
-$2.20
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
1,590
798
1,216
+99.2%
Capital expenditure
548
562
578
-2.5%
Free cash flow
1,042
236
638
+341.5%
Free cash flow margin
7.0%
1.5%
3.8%
Cash from investing
656
1,523
863
-56.9%
Cash from financing
-1,487
-2,172
-1,885
Depreciation and amortisation
1,308
1,330
1,557
-1.7%
Share-based compensation
124
119
129
+4.2%
Diluted shares, weighted
1,110m
1,107m
1,095m
+0.3%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
7,804
10,278
10,026
-24.1%
Non-controlling interest
794
966
1,035
-17.8%
Debt
21,212
23,043
25,919
-7.9%
Operating lease liabilities
349
416
479
-16.1%
Other liabilities
13,847
12,963
13,181
+6.8%
Total liabilities and equity
44,006
47,666
50,640
-7.7%
Fixed assets
5,739
5,982
6,296
-4.1%
Goodwill
17,177
17,633
20,624
-2.6%
Intangible assets
6,270
7,466
8,923
-16.0%
Cash and equivalents
2,801
2,165
2,177
+29.4%
Receivables
3,696
4,529
4,581
-18.4%
Inventory
3,833
3,818
4,403
+0.4%
Other assets
4,490
6,073
3,636
-26.1%
Total assets
44,006
47,666
50,640
-7.7%
10-K for the year ended 31 December 2022, filed 10 February 2023: the filing.